When DarioHealth (NSDQ:DRIO) CEO Erez Raphael looks at the medical device world, he sees solutions that were designed by healthcare professionals and doctors – and this presents a stark contrast with the consumer device industry.
“We have seen there are a lot of cases, most of the cases in the industry, where the overall user experience of an existing device is very professional-centric and not user-centric,” he told Drug Delivery Business News.
User experience is at the heart of DarioHealth’s design mentality, according to Raphael, among other related measures like user engagement and data collection.
Diabetes is a crowded industry, with companies like Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and Dexcom (NSDQ:DXCM) investing millions into creating and selling solutions for people to monitor and manage the chronic condition. But DarioHealth stands out, Raphael said, because of its product.
“In order to provide the best user experience, we thought that we don’t want to create some kind of second device that can be synced with the smartphone,” he explained. “We literally want to extend the smartphone to be a medical device.”